Skip to main content
Top
Published in: Diabetologia 7/2006

01-07-2006 | Commentary

Iron and glucose homeostasis: new lessons from hereditary haemochromatosis

Author: J. G. Wilson

Published in: Diabetologia | Issue 7/2006

Login to get access

Excerpt

Interest in the relationship between systemic iron stores and glucose homeostasis has existed since the early descriptions of hereditary haemochromatosis [1, 2]. Diabetes is also prevalent in transfusional iron overload and African iron overload, which resembles haemochromatosis clinically but has a different genetic mechanism. These findings, and studies showing that glucose intolerance in iron overload states can sometimes be prevented or ameliorated by iron removal, have left little doubt that increased tissue iron can contribute to glucose intolerance and diabetes. The actual prevalence of diabetes in haemochromatosis is unknown, with a broad range of estimates reported by different studies. Prevalence assessments have been confounded by selection bias, in that diabetes is considered a diagnostic feature of haemochromatosis. To date, studies of the mechanism(s) of haemochromatosis-associated diabetes have been limited. Thus, discussions of its pathogenesis have drawn heavily on findings in transfusional iron overload, and have been influenced by extensive and elegant studies of type 2 diabetes [3, 4]. In this issue of Diabetologia, McClain et al. provide a combined report of an extensive chart review and a prospective study of newly diagnosed patients with haemochromatosis, to address both the prevalence and mechanism of impaired glucose tolerance and diabetes in this disorder [5]. …
Literature
1.
go back to reference Fernandez-Real JM, Lopez-Bermejo A, Ricart W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51:2348–2354PubMedCrossRef Fernandez-Real JM, Lopez-Bermejo A, Ricart W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51:2348–2354PubMedCrossRef
2.
go back to reference Wilson JG, Lindquist JH, Grambrow SC, Crook ED, Maher JF (2003) Potential role of increased iron stores in diabetes. Am J Med Sci 325:332–339PubMedCrossRef Wilson JG, Lindquist JH, Grambrow SC, Crook ED, Maher JF (2003) Potential role of increased iron stores in diabetes. Am J Med Sci 325:332–339PubMedCrossRef
3.
go back to reference DeFronzo RA (1988) The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMed DeFronzo RA (1988) The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687PubMed
4.
go back to reference Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMedCrossRef Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMedCrossRef
5.
go back to reference McClain DA, Abraham D, Rogers J et al High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia DOI:10.1007/s00125-006-0200-0 McClain DA, Abraham D, Rogers J et al High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia DOI:10.1007/s00125-006-0200-0
6.
go back to reference Cooksey RC, Jouihan HA, Ajioka RS et al (2004) Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145:5305–5312PubMedCrossRef Cooksey RC, Jouihan HA, Ajioka RS et al (2004) Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145:5305–5312PubMedCrossRef
7.
go back to reference Hramiak IM, Finegood DT, Adams PC (1997) Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 20:110–118PubMed Hramiak IM, Finegood DT, Adams PC (1997) Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 20:110–118PubMed
8.
go back to reference Dymock IW, Cassar J, Pyke DA, Oakley WG, Williams R (1972) Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med 52:203–210PubMedCrossRef Dymock IW, Cassar J, Pyke DA, Oakley WG, Williams R (1972) Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med 52:203–210PubMedCrossRef
9.
go back to reference Niederau C, Berger M, Stremmel W et al (1984) Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 26:441–444PubMedCrossRef Niederau C, Berger M, Stremmel W et al (1984) Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 26:441–444PubMedCrossRef
10.
go back to reference Cario H, Holl RW, Debatin KM, Kohne E (2003) Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 162:139–146PubMed Cario H, Holl RW, Debatin KM, Kohne E (2003) Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 162:139–146PubMed
11.
go back to reference Williams R, Smith PM, Spicer EJF, Barry M, Sherlock S (1969) Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients. Q J Med 38:1–16PubMed Williams R, Smith PM, Spicer EJF, Barry M, Sherlock S (1969) Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients. Q J Med 38:1–16PubMed
Metadata
Title
Iron and glucose homeostasis: new lessons from hereditary haemochromatosis
Author
J. G. Wilson
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0289-1

Other articles of this Issue 7/2006

Diabetologia 7/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.